<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05068128</url>
  </required_header>
  <id_info>
    <org_study_id>PI2021_843_0017</org_study_id>
    <nct_id>NCT05068128</nct_id>
  </id_info>
  <brief_title>Combined Flow and Pressure Study of Craniospinal Dynamic</brief_title>
  <acronym>REVERT</acronym>
  <official_title>Combined Flow-pressure Study of Cerebrospinal Circulation Using CSF Perfusion Tests and Phase-contrast MRI - Reversible Dementia Substudy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Normal pressure hydrocephalus (NPH) can cause a type of dementia. However, this type of&#xD;
      dementia is the only one that is reversible. To treat this dementia it is necessary to&#xD;
      evacuate the accumulation of CSF from the brain to another body cavity using a device called&#xD;
      a shunt. But the implantation of this shunt is only effective when the cause of the pathology&#xD;
      is an alteration of the normal circulation of the CSF. To diagnose these patients,&#xD;
      morphological MRI and lumbar puncture are standard approaches used but remain perfectible in&#xD;
      diagnostic terms.&#xD;
&#xD;
      The main objective is to build a new model of the interaction of intracranial pressures and&#xD;
      fluids in order to obtain a new parameter allowing to obtain information on the cerebral&#xD;
      biomechanics.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2021</start_date>
  <completion_date type="Anticipated">September 2024</completion_date>
  <primary_completion_date type="Anticipated">September 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Variation of number of MRICP parameters according of CSF accumulation</measure>
    <time_frame>up to 3 years</time_frame>
    <description>The MRICP parameter will combine the CSF pressure and CSF flows. MRICP parameter results of the interaction of intracranial pressures and fluids in order allowing to obtain information on the cerebral biomechanics.&#xD;
Accumulation of CSF from the brain to another body cavity is neccessary to be determined.</description>
  </primary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Intracranial Pressure</condition>
  <condition>Cerebral Blood Flows</condition>
  <condition>Infusion Test</condition>
  <condition>Phase Contrast MRI</condition>
  <condition>Hydrocephalus</condition>
  <condition>Dementia</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Flow MRI</intervention_name>
    <description>4 flow acquisitions based on the 2D cine phase contrast sequence (present on all MRI systems) will be performed.&#xD;
This sequence requires a cardiac synchronization by a plethysmograph put on the patient's finger.&#xD;
32 cardiac phases are reconstructed per acquisition. The processing of the flow MRIs and the analysis of the flow curves of the LCS and blood during the cardiac cycle will be performed using the Amiens software.&#xD;
Parameters measured via flow MRI are:&#xD;
- Cerebral vascular flow, intracranial LCS dynamic volume, extracranial LCS dynamic volume</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PERFUSION TEST</intervention_name>
    <description>The test will be performed will include:&#xD;
Inserting a needle into the lumbar space, Ommaya reservoir or valve pre-chamber, as appropriate&#xD;
Connect the needle to the pressure transducer via saline filled manometer lines connected via a 3-way valve. The other end of the 3-way connection will be connected to a saline&#xD;
Recording of the opening pressure for 10 minutes&#xD;
The infusion test is terminated either when the pressure stabilizes again on a new plateau, or when the average pressure exceeds 40 mmHg, or in case of adverse effects or symptoms such as headache, nausea/vomiting or visual disturbances.&#xD;
At the end of the test, a depletion of 30 to 50 mL of CSF will be performed.&#xD;
The pressure recording during the test is then used to calculate the parameters of the mechanical properties of the CSF circulation and reported to the neurosurgeon ordering the test.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with suspected active hydrocephalus (HA) known as &quot;normal pressure&quot; and with Flow&#xD;
        MRI and CSF infusion test.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age &gt; 55 years&#xD;
&#xD;
          -  Patients with suspected active hydrocephalus (HA) known as &quot;normal pressure&quot;:&#xD;
&#xD;
          -  Ventricular dilatation: Evans index &gt; 0.3&#xD;
&#xD;
          -  Patients with cognitive impairment, and/or gait disorders and/or urinary incontinence&#xD;
             or a combination of these three symptoms.&#xD;
&#xD;
          -  Absence of other neurological diseases that could cause ventriculomegaly.&#xD;
&#xD;
          -  Information and collection of the patient's non opposition&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  All patients with neurological disease other than active hydrocephalus will be&#xD;
             excluded.&#xD;
&#xD;
          -  Individuals who cannot tolerate an MRI examination&#xD;
&#xD;
          -  All individuals with implants, pacemakers, prostheses and ferromagnetic objects&#xD;
&#xD;
          -  Patients under guardianship, curators or safeguard of justice&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Olivier Baledent, Dr</last_name>
    <phone>(33)322089520</phone>
    <email>Olivier.Baledent@chu-amiens.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Amiens</name>
      <address>
        <city>SalouÃ«l</city>
        <zip>80480</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier Baledent, DR</last_name>
      <phone>(33)322089520</phone>
      <email>baledent.olivier@chu-amiens.fr</email>
    </contact>
    <investigator>
      <last_name>Alin Bohra, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cyril Capel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 7, 2021</study_first_submitted>
  <study_first_submitted_qc>September 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 5, 2021</study_first_posted>
  <last_update_submitted>October 7, 2021</last_update_submitted>
  <last_update_submitted_qc>October 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Intracranial pressure</keyword>
  <keyword>cerebral blood flows</keyword>
  <keyword>infusion test</keyword>
  <keyword>Phase contrast MRI</keyword>
  <keyword>Hydrocephalus</keyword>
  <keyword>Dementia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Hydrocephalus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

